Browsing: Longevity Risk
Longevity and Mortality Investor’s coverage of bulk purchase annuity transactions. We are a leading source globally for longevity risk analysis, commentary and insights.
£30m buy-in transaction secures the future retirement benefits for more than 145 pensioners and 80 deferred members.
The deal secures the benefits of both deferred and pensioner members and was completed in January 2026.
Efforts to find treatments that slow or prevent Alzheimer’s disease are making good progress, but the complexities of tackling the illness…
LifeRoc Capital’s Brandon Marz provides his thoughts on the state of the life settlement industry’s secondary market in this month’s Q&A.
Latest CMI model not likely to have material impact on pensions de-risking activity.
£7m bulk purchase annuity buy-in covers all remaining members not previously insured and represents a further step in reducing risk for the Scheme.
New premium for single-premium products — both buy-out and buy-in contracts — surged 132% in the fourth quarter to $28bn, according to LIMRA’s U.S. Group Annuity Risk Transfer Sales Survey.
$2bn liability longevity reinsurance transaction is the firm’s first covering US retirees.
£105m full-scheme bulk purchase annuity buy-in with Canada Life secures the future benefits of over 350 deferred members and over 1,450 pensioners.
Together, the transactions cover an amount of approximately €8bn in pension liabilities and roughly half of Achmea Pension & Life Insurance’s longevity risk exposure.